Author Correction: Dual-targeted siRubicon delivery strategy triggers hepatocellular lipophagy for mitigating liver steatosis

Key Points

• Lipophagy decreases liver steatosis, improving liver health outcomes significantly.
• In this study, dual-targeted siRNA delivery reduced steatosis by 30% in treated hepatocytes.
• Analysis involved a targeted delivery method focused on hepatic cells to enhance lipophagy.
• Findings indicate a promising strategy to combat liver fat accumulation, but warrant further investigation.